Severe To Profound Hearing Loss clinical trials

Explore recruiting severe to profound hearing loss clinical trials.

Recruiting severe to profound hearing loss studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Severe To Profound Hearing Loss trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase I/II, open-ended, adaptative, open label dose escalation and expansion clinical trial to evaluate the efficacy and safety of unilateral intracochlear injection of SENS-501 using an injection system in children with severe to profound hearing loss due to Otoferlin gene mutations

Italy, France, Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Severe To Profound Hearing Loss trials by city

Severe To Profound Hearing Loss in Toronto Severe To Profound Hearing Loss in Vancouver Severe To Profound Hearing Loss in Montreal Severe To Profound Hearing Loss in Calgary Severe To Profound Hearing Loss in Edmonton Severe To Profound Hearing Loss in Ottawa Severe To Profound Hearing Loss in Winnipeg Severe To Profound Hearing Loss in Quebec City Severe To Profound Hearing Loss in Hamilton Severe To Profound Hearing Loss in Kitchener Severe To Profound Hearing Loss in London Severe To Profound Hearing Loss in Halifax Severe To Profound Hearing Loss in New York Severe To Profound Hearing Loss in Los Angeles Severe To Profound Hearing Loss in Chicago Severe To Profound Hearing Loss in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease